NFKB1 and Cognitive impairment: Numerous studies have demonstrated the critical role of NF‐κB signaling in cognitive impairment associated with diseases such as multiple sclerosis, attention deficit disorder, Parkinson's disease, and diabetes‐related cognitive dysfunction.